Source: http://www.wvlegislature.gov/bill_status/bills_text.cfm?billdoc=sb586%20intr.htm&yr=2008&sesstype=RS&i=586
Timestamp: 2018-02-21 08:15:08
Document Index: 557636678

Matched Legal Cases: ['§30', '§30', '§30', '§30', '§30', '§30', '§30', '§30']

(By Senators Prezioso, McCabe, Kessler and Yoder)
[Introduced February 6, 2008; referred to the Committee on Health and Human Resources; and then to the Committee on the Judiciary.]
A BILL to amend and reenact §30-5-1b of the Code of West Virginia, 1931, as amended; and to amend said code by adding thereto two new sections, designated §30-5-6b and §30-5-30, all relating generally to the scope of practice of pharmacists; defining terms; authorizing pharmacists to remotely dispense and deliver prescription drugs; authorizing pharmacists to administer certain specified immunizations; requiring pharmacists complete approved vaccine administration courses; providing that pharmacists may not delegate the authority to administer vaccines; and authorizing legislative rule-making authority.
That §30-5-1b of the Code of West Virginia, 1931, as amended, be amended and reenacted; and that said code be amended by adding thereto two new sections, designated §30-5-6b and §30-5-30, all to read as follows:
(4) "Collaborative pharmacy practice agreement" is a written and signed agreement between a pharmacist, a physician and the individual patient, or the patient's authorized representative who has granted his or her informed consent, that provides for collaborative pharmacy practice for the purpose of drug therapy management of a patient, which has been approved by the Board of Pharmacy, the Board of Medicine in the case of an allopathic physician or the West Virginia Board of Osteopathy in the case of an osteopathic physician.
(14) "Electronic data intermediary" means an entity that provides the infrastructure to connect a computer system, hand-held electronic device or other electronic device used by a prescribing practitioner with a computer system or other electronic device used by a pharmacist to facilitate the secure transmission of:
(16) "Intern" means an individual who is:
(17) "Labeling" means the process of preparing and affixing a label to a drug container exclusive, however, of a labeling by a manufacturer, packer or distributor of a nonprescription drug or commercially packaged legend drug or device. Any label shall include all information required by federal law or regulation and state law or rule.
(18) "Mail-order pharmacy" means a pharmacy, regardless of its location, which dispenses greater than ten percent prescription drugs via the mail.
(19) "Manufacturer" means a person engaged in the manufacture of drugs or devices.
(20) "Manufacturing" means the production, preparation, propagation or processing of a drug or device, either directly or indirectly, by extraction from substances of natural origin or independently by means of chemical or biological synthesis and includes any packaging or repackaging of the substance or substances or labeling or relabeling of its contents and the promotion and marketing of the drugs or devices. Manufacturing also includes the preparation and promotion of commercially available products from bulk compounds for resale by pharmacies, practitioners or other persons.
(21) "Clinical medical home" means a clinic where a patient's care includes the development of a plan of care, the determination of the outcomes desired, facilitation and navigation of the health care system, provision of follow-up and support for achieving the identified outcomes. The clinical medical home maintains a centralized, comprehensive record of all health related services to provide continuity of care.
(19) (22) "Nonprescription drug" means a drug which may be sold without a prescription and which is labeled for use by the consumer in accordance with the requirements of the laws and rules of this state and the federal government.
(20) (23) "Patient counseling" means the oral communication by the pharmacist of information, as defined in the rules of the board, to the patient to improve therapy by aiding in the proper use of drugs and devices.
(21) (24) "Person" means an individual, corporation, partnership, association or any other legal entity, including government.
(22) (25) "Pharmaceutical care" is the provision of drug therapy and other pharmaceutical patient care services intended to achieve outcomes related to the cure or prevention of a disease, elimination or reduction of a patient's symptoms or arresting or slowing of a disease process as defined in the rules of the board.
(23) (26) "Pharmacist" or "registered pharmacist" means an individual currently licensed by this state to engage in the practice of pharmacy and pharmaceutical care.
(24) (27) "Pharmacist-in-charge" means a pharmacist currently licensed in this state who accepts responsibility for the operation of a pharmacy in conformance with all laws and rules pertinent to the practice of pharmacy and the distribution of drugs and who is personally in full and actual charge of the pharmacy and personnel.
(25) (28) "Pharmacist's scope of practice pursuant to the collaborative pharmacy practice agreement" means those duties and limitations of duties placed upon the pharmacist by the collaborating physician, as jointly approved by the Board of Pharmacy and the Board of Medicine or the Board of Osteopathy.
(26) (29) "Pharmacy" means any drugstore, apothecary or place within this state where drugs are dispensed and sold at retail or displayed for sale at retail and pharmaceutical care is provided and any place outside of this state where drugs are dispensed and pharmaceutical care is provided to residents of this state.
(27) (30) "Physician" means an individual currently licensed, in good standing and without restrictions, as an allopathic physician by the West Virginia Board of Medicine, or an osteopathic physician by the West Virginia Board of Osteopathy.
(28) (31) "Pharmacy technician" means registered supportive personnel who work under the direct supervision of a pharmacist who have passed an approved training program as described in this article.
(29) (32) "Practitioner" means an individual currently licensed, registered or otherwise authorized by any state, territory or district of the United States to prescribe and administer drugs in the course of professional practices, including allopathic and osteopathic physicians, dentists, physician's assistants, optometrists, veterinarians, podiatrists and nurse practitioners as allowed by law.
(30) (33) "Preceptor" means an individual who is currently licensed as a pharmacist by the board, meets the qualifications as a preceptor under the rules of the Board and participates in the instructional training of pharmacy interns.
(31) (34) "Prescription drug" or "legend drug" means a drug which, under federal law, is required, prior to being dispensed or delivered, to be labeled with either of the following statements:
(32) (35) "Prescription drug order" means a lawful order of a practitioner for a drug or device for a specific patient.
(33) (36) "Prospective drug use review" means a review of the patients' drug therapy and prescription drug order, as defined in the rules of the Board, prior to dispensing the drug as part of a drug regimen review.
(34) (37) "USP-DI" means the United States pharmacopeia- dispensing information.
(35) (38) "Wholesale distributor" means any person engaged in wholesale distribution of drugs, including, but not limited to, manufacturers' and distributors' warehouses, chain drug warehouses and wholesale drug warehouses, independent wholesale drug trader and retail pharmacies that conduct wholesale distributions.
To improve patient access to prescription drugs, the board shall propose legislative rules pursuant to article three, chapter twenty-nine-a of this code, to permit pharmacists to remotely dispense and deliver prescription drugs filled by a licensed pharmacist to a patient's clinical medical home for dispensing to the patient. The legislative rule shall provide for patient counseling by a licensed pharmacist via telephone or video link.
(a) A pharmacist licensed under the provisions of this article and meeting the requirements of this section may administer the influenza immunization to any person eighteen years of age or older under joint legislative rules promulgated jointly by the Board of Pharmacy, the Board of Medicine and the Osteopathy Board in accordance with the provisions of section twenty-eight of this article. These legislative rules shall be administered by the Board of Pharmacy.
(b) The joint legislative rules shall, at a minimum:
(1) Establish a course, or provide a list of approved courses, in immunization administration. The courses must be based on the standards established for such courses by the centers for disease control and prevention in the public health service of the United States Department of Health and Human Services;
(2) Set forth definitive treatment guidelines, established by a physician, which shall include, but not be limited to, appropriate observation for an adverse reaction of an individual following an immunization;
(3) Provide that to administer immunizations, a pharmacist shall complete an American Red Cross or American Heart Association basic life-support training, and maintain certification in the same. The immunizations shall be administered in accordance with the treatment guidelines established in the rule;
(4) Set forth continuing education requirements for pharmacists administering immunization;
(5) Provide requirements for pharmacists administering immunizations to report to the primary care physician or other licensed health care provider as identified by the person receiving the immunization and to the West Virginia Statewide Immunization Information System; and
(6) Provide any other procedures necessary to implement the provisions of this section.
(c) A pharmacist may not delegate the authority to administer immunizations to any other person.
NOTE: The purpose of this bill is to expand the scope of practice of pharmacists to allow them to remotely dispense and deliver prescription drugs and to administer certain specified vaccinations.
§30-5-6b and §30-5-30 are new; therefore, strike-throughs and underscoring have been omitted.